Shashank Shekher Mishra

Shashank Shekher Mishra

Auto-generated profile, based on publicly available information

Shashank Shekher Mishra

School of Pharmaceutical and Population Health Informatics, Faculty of Pharmacy DIT University Dehradun India

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

20 May 2025 in Journal of Molecular Structure
Verified
Journal Article
Closed access
VJVibha Joshi
Vibha Joshi
VBVishwajeet Bachhar
Vishwajeet Bachhar
ANArushi Negi
Arushi Negi
SMShashank Shekher Mishra
Shashank Shekher Mishra
MDManisha Duseja
Manisha Duseja

18 March 2025 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
VJVibha Joshi
Vibha Joshi
VBVishwajeet Bachhar
Vishwajeet Bachhar
SMShashank Shekher Mishra
Shashank Shekher Mishra
RSRavi K. Shukla
Ravi K. Shukla
NKNeeraj Kumar
Neeraj Kumar
MDManisha Duseja
Manisha Duseja

21 July 2023 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
VDVagish Dwibedi
Vagish Dwibedi
SMShashank Shekher Mishra
Shashank Shekher Mishra
NGNancy George
Nancy George
MJMahavir Joshi
Mahavir Joshi
GKGursharan Kaur
Gursharan Kaur
SRSANTOSH KUMAR RATH
SANTOSH KUMAR RATH
Fungal endophytes are a known warehouse of bioactive compounds with multifarious applications. In the present investigation two compounds, β-Sitosterol (1) and ursolic acid (2), were isolated from Alternaria alternata, an endophytic fungus associated with Morus alba Linn for the first time. The structure of the compounds was elucidated on the basis of comprehensive spectral analysis (UV, IR, 1 H-, 13 C- and 2D-NMR, as well as HRESI-MS). In the in vitro alpha amylase inhibitory assay both compounds (1) and (2) show potent antidiabetic activity. In support, Docking studies indicate significant binding affinity of the isolated compounds. Hence from the present study, it can be concluded that endophytic fungi in Morus alba Linn can find use in antidiabetic drug development in the medicinal industry.Communicated by Ramaswamy H. Sarma.

12 June 2017 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
NKNeeraj Kumar
Neeraj Kumar
SMShashank Shekhar Mishra
Shashank Shekhar Mishra
CSChandra Sharma
Chandra Sharma
HSHamendra Pratap Singh
Hamendra Pratap Singh
SKSourav Kalra
Sourav Kalra
Despite the various research efforts toward the treatment of stress-related disorders, the drug has not yet launched last 20 years. Corticotropin releasing factor-1 receptor antagonists have been point of great interest in stress-related disorders. In the present study, we have selected benzazole scaffold-based compounds as corticotropin releasing factor-1 antagonists and performed 2D and 3D QSAR studies to identify the structural features to elucidating the binding mechanism prediction. The best 2D QSAR model was obtained through multiple linear regression method with r2 value of .7390, q2 value of .5136 and pred_r2 (predicted square correlation coefficient) value of .88. The contribution of 2D descriptor, T_2_C_1 was 60% (negative contribution) and 4pathClusterCount was 40.24% (positive contribution) in enhancing the activity. Also 3D QSAR model was statistically significant with q2 value of .9419 and q2_se (standard error of internal validation) value of .19. Statistical parameters results prove the robustness and significance of both models. Further, molecular docking and pharmacokinetic analysis was performed to explore the scope of investigation. Docking results revealed that the all benzazole compounds show hydrogen bonding with residue Asn283 and having same hydrophobic pocket (Phe286, Leu213, Ile290, Leu287, Phe207, Arg165, Leu323, Tyr327, Phe284, and Met206). Compound B14 has higher activity compare to reference molecules. Most of the compounds were found within acceptable range for pharmacokinetic parameters. This work provides the extremely useful leads for structural substituents essential for benzimidazole moiety to exhibit antagonistic activity against corticotropin releasing factor-1 receptors.

14 November 2024 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
SRSaumya Rastogi
Saumya Rastogi
SMShashank Shekher Mishra
Shashank Shekher Mishra
LSLakhveer Singh
Lakhveer Singh
NKNeeraj Kumar
Neeraj Kumar